Location History:
- Fremont, CA (US) (1991 - 1993)
- Sonora, CA (US) (2009 - 2010)
Company Filing History:
Years Active: 1991-2010
Title: An Insight into Inventor Roy D. Archibald: Innovator in Antibiotic Formulations
Introduction: Roy D. Archibald, a distinguished inventor based in Fremont, California, has made noteworthy contributions to the field of pharmaceuticals, particularly in antibiotic formulations. With a total of five patents to his name, his innovative work continues to impact medical treatment options.
Latest Patents: Archibald's most recent patents showcase his ingenuity in developing concentrated aqueous azalide formulations. These formulations encompass concentrated antibiotic solutions designed to treat a variety of infections, including pulmonary, nasopharyngeal, otic, ocular, dermal, and vaginal infections. His method involves dissolving an azalide antibiotic in an aqueous solution that contains a strong acid. This innovative approach not only improves the effectiveness of antibiotic delivery but also opens up new avenues for treating infections.
Career Highlights: Throughout his career, Archibald has worked with reputable organizations, including Insite Vision Corporation and Catalent Pharma Solutions, LLC. His experience in these companies has provided him with a robust foundation in pharmaceutical research and development, further allowing him to refine his innovative ideas into patentable inventions.
Collaborations: In the course of his career, Archibald has collaborated with notable professionals such as Santosh K. Chandrasekaran and Jeffrey P. Davis. These partnerships have enabled the exchange of ideas and expertise, resulting in groundbreaking advancements in antibiotic formulations.
Conclusion: Roy D. Archibald exemplifies the spirit of innovation within the pharmaceutical industry. His patents reflect his commitment to advancing medical treatment through effective antibiotic formulations. As the medical field continues to evolve, inventors like Archibald are vital in addressing public health challenges and improving patient outcomes.